Cargando…

Galactooligosaccharide Mediates NF-κB Pathway to Improve Intestinal Barrier Function and Intestinal Microbiota

The use of antibiotics to treat diarrhea and other diseases early in life can lead to intestinal disorders in infants, which can cause a range of immune-related diseases. Intestinal microbiota diversity is closely related to dietary intake, with many oligosaccharides impacting intestinal microorgani...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xi, Menglu, Hao, Guo, Yao, Qi, Duan, Xuchang, Ge, Wupeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674247/ https://www.ncbi.nlm.nih.gov/pubmed/38005333 http://dx.doi.org/10.3390/molecules28227611

Ejemplares similares

HO-1/CO Maintains Intestinal Barrier Integrity through NF-κB/MLCK Pathway in Intestinal HO-1(−/−) Mice
por: Zhang, Zhenling, et al.
Publicado: (2021)

Characterization of the Intestinal Lactobacilli Community following Galactooligosaccharides and Polydextrose Supplementation in the Neonatal Piglet
por: Hoeflinger, Jennifer L., et al.
Publicado: (2015)

Chitosan Oligosaccharides Alleviate Colitis by Regulating Intestinal Microbiota and PPARγ/SIRT1-Mediated NF-κB Pathway
por: Guo, Congcong, et al.
Publicado: (2022)

Embelin alleviates weaned piglets intestinal inflammation and barrier dysfunction via PCAF/NF-κB signaling pathway in intestinal epithelial cells
por: Yao, Weilei, et al.
Publicado: (2022)

Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics
por: Krumbeck, Janina A., et al.
Publicado: (2018)

Icariin enhances intestinal barrier function by inhibiting NF-κB signaling pathways and modulating gut microbiota in a piglet model
por: Xiong, Wen, et al.
Publicado: (2019)

Effects of Docetaxel Injection and Docetaxel Micelles on the Intestinal Barrier and Intestinal Microbiota
por: Liu, Qingya, et al.
Publicado: (2021)

Modulation of microbial communities and mucosal gene expression in chicken intestines after galactooligosaccharides delivery In Ovo
por: Slawinska, Anna, et al.
Publicado: (2019)

Comments on “Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics”
por: Ranneh, Yazan, et al.
Publicado: (2023)

Therapeutic Mechanisms of Berberine to Improve the Intestinal Barrier Function via Modulating Gut Microbiota, TLR4/NF-κ B/MTORC Pathway and Autophagy in Cats
por: Cao, JingWen, et al.
Publicado: (2022)

Retraction: Icariin enhances intestinal barrier function by inhibiting NF-κB signaling pathways and modulating gut microbiota in a piglet model
por: Xiong, Wen, et al.
Publicado: (2023)

Saccharomyces boulardii modulates necrotizing enterocolitis in neonatal mice by regulating the sirtuin 1/NF-κB pathway and the intestinal microbiota
por: Zhang, Kun, et al.
Publicado: (2020)

Oxymatrine Improves Intestinal Epithelial Barrier Function Involving NF-κB-Mediated Signaling Pathway in CCl(4)-Induced Cirrhotic Rats
por: Wen, Jian-Bo, et al.
Publicado: (2014)

Epithelial PBLD attenuates intestinal inflammatory response and improves intestinal barrier function by inhibiting NF-κB signaling
por: Chen, Shengbo, et al.
Publicado: (2021)

Alginate Oligosaccharides Ameliorate DSS-Induced Colitis through Modulation of AMPK/NF-κB Pathway and Intestinal Microbiota
por: Zhang, Yue, et al.
Publicado: (2022)

Protective Role of Somatostatin in Sepsis-Induced Intestinal Barrier Dysfunction through Inhibiting the Activation of NF-κB Pathway
por: Xu, Xin, et al.
Publicado: (2020)

Pinocembrin alleviates ulcerative colitis in mice via regulating gut microbiota, suppressing TLR4/MD2/NF-κB pathway and promoting intestinal barrier
por: Yue, Bei, et al.
Publicado: (2020)

Escherichia coli Nissle 1917 Protects Intestinal Barrier Function by Inhibiting NF-κB-Mediated Activation of the MLCK-P-MLC Signaling Pathway
por: Guo, Shihao, et al.
Publicado: (2019)

Effects of a Trans-Galactooligosaccharide on Biochemical Blood Parameters and Intestine Morphometric Parameters of Common Carp (Cyprinus carpio L.)
por: Ziółkowska, Ewa, et al.
Publicado: (2020)

Zengshengping improves lung cancer by regulating the intestinal barrier and intestinal microbiota
por: Sun, E., et al.
Publicado: (2023)

Inhibition of IRAK 1/4 alleviates colitis by inhibiting TLR 4/NF-κB pathway and protecting the intestinal barrier
por: Yan, Bo, et al.
Publicado: (2022)

Fermented Sargassum fusiforme Mitigates Ulcerative Colitis in Mice by Regulating the Intestinal Barrier, Oxidative Stress, and the NF-κB Pathway
por: Zhang, Siteng, et al.
Publicado: (2023)

Sialyllactose and Galactooligosaccharides Promote Epithelial Barrier Functioning and Distinctly Modulate Microbiota Composition and Short Chain Fatty Acid Production In Vitro
por: Perdijk, Olaf, et al.
Publicado: (2019)

Intestinal injury following liver transplantation was mediated by TLR4/NF-κB activation-induced cell apoptosis
por: YUAN, DONG-DONG, et al.
Publicado: (2016)

Determination of β-Galactooligosaccharides by Liquid Chromatography
por: Austin, Sean, et al.
Publicado: (2014)

Inhibitory Effect of Galactooligosaccharide on Skin Pigmentation
por: Suh, Min Geun, et al.
Publicado: (2019)

Early flora colonization affects intestinal immunoglobulin G uptake in piglets, which may be mediated by NF-κB-FcRn pathway
por: Peng, Fang, et al.
Publicado: (2023)

Stilbenoid compounds inhibit NF-κB-mediated inflammatory responses in the Drosophila intestine
por: Aalto, Anna L., et al.
Publicado: (2023)

Oregano Essential Oils Mediated Intestinal Microbiota and Metabolites and Improved Growth Performance and Intestinal Barrier Function in Sheep
por: Jia, Li, et al.
Publicado: (2022)

Bifidobacterium longum and Galactooligosaccharide Improve Skin Barrier Dysfunction and Atopic Dermatitis-like Skin
por: Kim, Sukyung, et al.
Publicado: (2022)

Intestinal homeostasis and inflammation: Gut microbiota at the crossroads of pancreas–intestinal barrier axis
por: Zhang, Zhongwei, et al.
Publicado: (2022)

Decreased TMIGD1 aggravates colitis and intestinal barrier dysfunction via the BANF1-NF-κB pathway in Crohn’s disease
por: Zhou, Longyuan, et al.
Publicado: (2023)

Maternal diet associated with infants’ intestinal microbiota mediated by predominant long-chain fatty acid in breast milk
por: Xi, Menglu, et al.
Publicado: (2023)

Combination of poly-γ-glutamic acid and galactooligosaccharide improves intestinal microbiota, defecation status, and relaxed mood in humans: a randomized, double-blind, parallel-group comparison trial
por: UMEDA, Kentaro, et al.
Publicado: (2022)

Matrix Metalloproteinase-9 (MMP-9) induced disruption of intestinal epithelial tight junction barrier is mediated by NF-κB activation
por: Al-Sadi, Rana, et al.
Publicado: (2021)

Corrigendum: Sialyllactose and Galactooligosaccharides Promote Epithelial Barrier Functioning and Distinctly Modulate Microbiota Composition and Short Chain Fatty Acid Production In Vitro
por: Perdijk, Olaf, et al.
Publicado: (2019)

Bifidobacterium bifidum Enhances the Intestinal Epithelial Tight Junction Barrier and Protects against Intestinal Inflammation by Targeting the Toll-like Receptor-2 Pathway in an NF-κB-Independent Manner
por: Al-Sadi, Rana, et al.
Publicado: (2021)

Intestinal microbiota-mediated dietary fiber bioavailability
por: Guo, Kangxiao, et al.
Publicado: (2022)

Colon contradictions: NF-κB signaling in intestinal tumorigenesis
por: Fordham, Robert P., et al.
Publicado: (2015)

Role of ROCK/NF-κB/AQP8 signaling in ethanol-induced intestinal epithelial barrier dysfunction
por: Zhao, Hang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e5n1865oji3snemkr35kpqf70q